Today, Thursday, 2012-02-23, a U.S. FDA advisory panel recommended the FDA approve the new weight-loss drug Qnexa. The advisory panel voted 20-2 vote for approval, saying Qnexa's benefits for the chronically obese outweighed potential risks the drug may pose, according to ABC News.
Qnexa is a combination of two drugs - phentermine, which is a stimulant, and topiramate, a migraine drug - also known by the name Topamax. An official approval or a rejection by the FDA of Qnexa is expected by April 17th.
Qnexa is a combination of two drugs - phentermine, which is a stimulant, and topiramate, a migraine drug - also known by the name Topamax. An official approval or a rejection by the FDA of Qnexa is expected by April 17th.
Why play the waiting game until April 17th?
Call 405-749-0900 TODAY and schedule an appointment to learn more & get started on the
Qnexa Approach to Weight Loss with one of our healthcare providers.
Why wait when you can get a jump start on the
Qnexa Approach to Weight Loss tailored specifically for you NOW !!!!
To learn more visit us on the web….
http://www.barretohealthcare.com/
No comments:
Post a Comment